Medical company Abbott has now launched a handful of coronavirus tests, and the U.S. is paying $750 million for 150 million of the most recently approved tests. So, is ABT stock a buy now?

The post Abbott Tacks On Massive Coronavirus Test Growth — But Is ABT Stock A Buy? appeared first on Investor's Business Daily.